Nancy Klimas
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID) (NCT07021794) | Nancy Klimas | 2025-06-16 |
Track Nancy Klimas automatically
Every clearance here is in the API, with alerts when new ones post.